Health

Zuberitamab (Anruixi®), the first domestically developed anti-CD20 antibody as a Class I innovative drug from BioRay Pharmaceutical, has been approved for marketing in China

SHANGHAI, Sept. 13, 2023 /PRNewswire/ -- Recently, BioRay Pharmaceutical Co., Ltd.  (hereinafter referred to as "Bioray") announced that its independently developed Class I innovative therapeutic biological product, Zuberitamab Injection (trade name: Anruixi®), indicated for the treatment of CD20...

2023-09-13 14:24 1226

Caliway Announces CBL-514 Phase 2 Study Topline Results for Dercum's Disease, Showing 64.5% of Lipomas with Complete Clearance or Dimensions Reduction of Over 50% and Reduced Pain by 4.7

-       CBL-0201DD Phase 2 study met the primary and all secondary endpoints. -       64.5% of painful lipomas showed complete clearance or dimensions reduction of more than 50% after CBL-514 treatments. -       54.8% of painful lipomas showed complete clearance or dimension reduction of more th...

2023-09-13 13:42 1144

AIRS Medical Inc. receives MDSAP Certification, Paving the Way for Global Expansion

SEOUL, South Korea, Sept. 13, 2023 /PRNewswire/ -- AIRS Medical Inc., an AI-powered healthcare solution provider headquartered in Korea announces the attainment of MDSAP (Medical Device Single Audit Program) certification. This milestone achievement underscores AIRS Medical's commitment to qualit...

2023-09-13 12:44 1245

91% of doctors in Southeast Asia participate in digital learning despite societal return to in-person interactions - Docquity

* Docquity survey shows that doctor attendance at digital learning events is higher than in-person events (at 3.9 versus 3.0 times per month) * While two learning cohorts have emerged - digital dominant learners and in-person dominant learners, both groups participate in digital learning yet ...

2023-09-13 10:55 642

Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf® in Taiwan and select South-East Asian markets

SINGAPORE, Sept. 13, 2023 /PRNewswire/ -- Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Astellas Pharma Inc. (Astellas) for the development, manufacturing and commercialization of the orally administered Janus kinase (JAK) inhibitor Smyraf® 50 mg and 100 ...

2023-09-13 10:30 2128

Maxigen Biotech Inc. Wins 2023 Asia's Leading SMEs Award for Innovative Sustainability

KUALA LUMPUR, Malaysia, Sept. 13, 2023 /PRNewswire/ -- Maxigen Biotech Inc.(MBI), a pioneering biotech company headquartered inTaiwan, has been honored with the prestigious 2023 Asia's Leading SMEs Award by ACES underscoring its commitment to innovation and sustainable operations.

2023-09-13 09:30 1724

GemPharmatech's Board Appoints Brandy Wilkinson, Ph.D. as its New Chief Executive Officer of GemPharmatech LLC.

SAN DIEGO, Sept. 12, 2023 /PRNewswire/ -- GemPharmatech LLC., a leading contract research organization, announced today that its Board of Directors has appointed Dr.Brandy Wilkinson as the Chief Executive Officer of its subsidiary inthe United States, effective September 12, 2023.

2023-09-13 00:00 1277

"Promoting Health, Wellness, and Community: Gowalking.com Unites Global Fitness Walkers for a Better World"

BOCA RATON, Fla., Sept. 12, 2023 /PRNewswire/ -- Today marks the launch of Gowalking.com, a groundbreaking start-up founded byJeremy Goldstein, with a mission to connect and empower the world's estimated 1.2 billion fitness walkers by providing a simple and innovative platform for finding and joi...

2023-09-12 22:30 2380

Frost & Sullivan Recognizes Suki AI with the 2023 North American Technology Leadership Award

Suki's innovative AI Assistant brings the power of Generative AI to health systems and delivers strong ROI SAN ANTONIO, Sept. 12, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the healthcare voice assistant industry and, based on its findings, recognizesSuki AI with the 2023 North Am...

2023-09-12 22:00 1549

Medmain Inc. Has Been Selected for the U.S. Market Gateway Accelerator for BioSciences and MedTech

FUKUOKA, Japan, Sept. 12, 2023 /PRNewswire/ -- Medmain Inc. ( https://en.medmain.com ), a Japanese medtech startup that offers PidPort, an AI-powered cloud system to assist in digital pathology, is pleased to announce that it has been selected for the "U.S. Market Gateway ...

2023-09-12 22:00 1460

TMRW Life Sciences Receives CE Mark for the CryoRobot Select, its Next-Generation Automated Platform to Safely Manage and Store Frozen Eggs and Embryos

TMRW's Cutting-Edge Technology is Raising the Standard of Care in Global Fertility NEW YORK, Sept. 12, 2023 /PRNewswire/ -- TMRW Life Sciences, a fertility technology company automating the IVF lab, today announced that it has received a CE Mark for the CryoRobot Select (CRS). The European desig...

2023-09-12 21:01 1486

Standigm's "Green Ribbon Campaign" to support Mitochondria Disease Awareness Week

SEOUL, South Korea, Sept. 12, 2023 /PRNewswire/ -- On September 5th, 2023 Standigm, a company using artificial intelligence (AI) technology for drug discovery and development launched, the "Green Ribbon Campaign," event to support the upcoming Mitochondrial Disease Awareness Week scheduled for Se...

2023-09-12 21:00 1224

CSafe Expands Executive Team with Chief Financial Officer

Seasoned financial leader, Anthony Pishotti, joins CSafe executive team to further drive the company's portfolio and geographic growth. MONROE, Ohio, Sept. 12, 2023 /PRNewswire/ -- CSafe, the largest active and passive temperature-controlled shipping solutions provider for the biopharmaceutical ...

2023-09-12 20:59 1769

Datasea Announces Pricing of $2.0 Million Underwritten Public Offering

BEIJING, Sept. 12, 2023 /PRNewswire/ -- Datasea Inc., (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada incorporated digital technology corporation engaged in converging and innovative business segments for intelligent acoustics and 5G messaging technology inChina, today announced the pricing ...

2023-09-12 20:30 4073

Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media

News Summary: * Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and Andrew+™ robot with upstream bioreactors to automate routine product quality and cell culture media analyses. * New pre-developed LC-MS analytical workflow...

2023-09-12 20:00 1426

New South Wales Government (NSW) Partner, Myeloid Therapeutics, Initiates Patient Dosing with MT-302 in Phase 1 Study at Clinical Site in Australia

NSW and Myeloid entered into a partnership in February 2023 to launch state-of-the-art GMP manufacturing RNA facility CAMBRIDGE, Mass., Sept. 12, 2023 /PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage oncology company, has dosed the first patient with MT-302 in a Phase 1 s...

2023-09-12 20:00 958

Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted Therapy Candidate for Patients Suffering From Non-Small Cell Lung Cancer With MET Alteration

CASTRES, France and BASEL, Switzerland, Sept. 12, 2023 /PRNewswire/ --  Pierre Fabre Laboratories , the French pharmaceutical and dermo-cosmetic company, announced the acquisition of Vertical Bio AG, a developer of novel cancer therapies. This first acquisition of...

2023-09-12 20:00 1231

Metabolon Launches New Biological Stress Discovery Panel to Aid Detection of Inflammation and Biological Stress Biomarkers

Metabolon's new Biological Stress Discovery Panel supports inflammation, immune function, and stress research with advanced analytics  MORRISVILLE, N.C., Sept. 12, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of research, di...

2023-09-12 19:57 1024

Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius' novel anti-PD-1 mAb HANSIZHUANG in MENA

* HANSIZHUANG's coverage footprint includes 22 emerging market countries acrossSoutheast Asia and MENA – * KGbio to develop and commercialise HANSIZHUANG in 12 MENA countries; Henlius to receiveUS$7 million upfront payment plus royalties and up to US$8 million in regulatory milestone payments...

2023-09-12 19:24 1215

The Korean Society of Ginseng confirms the effects of consuming red ginseng in the prevention and improvement of dementia

- Through the study "Elucidation of Mechanisms for Dementia Prevention and Improvement by Red Ginseng" SEOUL, South Korea, Sept. 12, 2023 /PRNewswire/ -- Through continuous research, the secrets of ginseng, a representative medicinal herb of Korea, are being revealed, showcasing its efficacy. Re...

2023-09-12 17:00 1608
1 ... 87888990919293 ... 813

Week's Top Stories